TRVN
Price:
$1.69
Market Cap:
$1.44M
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and...[Read more]
Industry
Biotechnology
IPO Date
2014-01-31
Stock Exchange
NASDAQ
Ticker
TRVN
According to Trevena, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.03. This represents a change of -87.27% compared to the average of -0.24 of the last 4 quarters.
The mean historical PE Ratio of Trevena, Inc. over the last ten years is -52.10. The current -0.03 PE Ratio has changed -94.24% with respect to the historical average. Over the past ten years (40 quarters), TRVN's PE Ratio was at its highest in in the December 2023 quarter at -0.17. The PE Ratio was at its lowest in in the September 2020 quarter at -485.91.
Average
-52.10
Median
-29.38
Minimum
-227.52
Maximum
-0.19
Discovering the peaks and valleys of Trevena, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.93%
Maximum Annual PE Ratio = -0.19
Minimum Annual Increase = -89.87%
Minimum Annual PE Ratio = -227.52
Year | PE Ratio | Change |
---|---|---|
2023 | -5.71 | 2.93% |
2022 | -0.19 | -89.87% |
2021 | -1.86 | -79.99% |
2020 | -9.30 | -86.46% |
2019 | -68.70 | 167.46% |
2018 | -25.69 | -22.35% |
2017 | -33.08 | -55.76% |
2016 | -74.79 | -67.13% |
2015 | -227.52 | 206.77% |
2014 | -74.16 | -58.76% |
The current PE Ratio of Trevena, Inc. (TRVN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.58
5-year avg
-17.15
10-year avg
-52.10
Trevena, Inc.’s PE Ratio is greater than AcelRx Pharmaceuticals, Inc. (-1.83), greater than Lipocine Inc. (-3.83), greater than Verastem, Inc. (-1.17), greater than vTv Therapeutics Inc. (-4.44), greater than Nabriva Therapeutics plc (-0.14),
Company | PE Ratio | Market cap |
---|---|---|
-1.83 | $14.58M | |
-3.83 | $32.57M | |
-1.17 | $156.95M | |
-4.44 | $34.06M | |
-0.14 | $4.55M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Trevena, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Trevena, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Trevena, Inc.'s PE Ratio?
How is the PE Ratio calculated for Trevena, Inc. (TRVN)?
What is the highest PE Ratio for Trevena, Inc. (TRVN)?
What is the 3-year average PE Ratio for Trevena, Inc. (TRVN)?
What is the 5-year average PE Ratio for Trevena, Inc. (TRVN)?
How does the current PE Ratio for Trevena, Inc. (TRVN) compare to its historical average?